Registry-based comparison of multiple sclerosis epidemiology trend data in 1999 and 2019: the case of Yaroslavl

Spirin N.N.; Kasatkin D.S.; Stepanov I.O.; Shipova E.G.; Baranova N.S.; Vinogradova T.V.; Molchanova S.S.; Kiselev D.V.; Shadrichev V.A.; Spirina N.N.; Kachura D.A.

doi:https://doi.org/10.17116/jnevro202012007248

Spirin N.N.

Yaroslavl State Medical University

RSCI AuthorID: 523232
Scopus AuthorID: 6603682550
ORCID: 0000-0001-9078-589X

Kasatkin D.S.

Yaroslavl State Medical University

Stepanov I.O.

Clinical hospital No. 2

Shipova E.G.

Yaroslavl State Medical University

Baranova N.S.

Yaroslavl State Medical University

Vinogradova T.V.

Yaroslavl State Medical University

Molchanova S.S.

Yaroslavl State Medical University

Kiselev D.V.

Yaroslavl State Medical University

Shadrichev V.A.

Yaroslavl State Medical University

Spirina N.N.

Yaroslavl State Medical University

SPIN RSCI: 1222-6768
Scopus AuthorID: 55673137900
ORCID: 0000-0002-5883-1216

Kachura D.A.

Yaroslavl regional clinical hospital

Registry-based comparison of multiple sclerosis epidemiology trend data in 1999 and 2019: the case of Yaroslavl

Authors:

Spirin N.N., Kasatkin D.S., Stepanov I.O., Shipova E.G., Baranova N.S., Vinogradova T.V., Molchanova S.S., Kiselev D.V., Shadrichev V.A., Spirina N.N., Kachura D.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7‑2): 48‑53

DOI: 10.17116/jnevro202012007248

Read: 1959 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Spirin NN, Kasatkin DS, Stepanov IO, et al. . Registry-based comparison of multiple sclerosis epidemiology trend data in 1999 and 2019: the case of Yaroslavl. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7‑2):48‑53. (In Russ.)
https://doi.org/10.17116/jnevro202012007248

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To compare the epidemiological indicators of multiple sclerosis (MS) in Yaroslavl when comparing the 1999 and 2019 registers to study the pathomorphism of the disease in this territory.

MATERIAL AND METHODS

During the work, the data of the 1999 and 2019 registers were used, including the age of the debut, the date of diagnosis, the form of the disease, clinical characteristics, the treatment received and its duration. In 1999, 257 patients living in the city of Yaroslavl (155 women and 102 men) were included in the MS registry with a reliable diagnosis of MS according to Poser’s criteria with confirmation according to neuroimaging data. In 2019, 479 people living in the territory of Yaroslavl (342 women and 137 men) were included in the register with a diagnosis of MS based on the criteria of MacDonald 2005, 2010, 2017. As of 01.01.19, 970 patients (530 women and 440 men) were included in the patient register of the Yaroslavl region.

RESULTS AND CONCLUSION

Clinical and epidemiological review of Yaroslavl MS Registry data in 1999 and 2019 showed significant changes in disease pattern. The prevalence rate increased from 42.6 to 78.5 cases per 100,000 people. The morbidity rate rose from 1.58 to 3.28 cases per 100,000 people. The reasons for the increase are improvement in the diagnostic quality, new diagnostic criteria and the true growth of prevalence and morbidity. The use of disease modifying drugs (DMDs) has extended «the time to EDSS 3,0» by 4 years, «the time to EDSS 6,0» by 5—8 years.

Keywords:

epidemiology

multiple sclerosis

pathomorphosis

disability

Authors:

Spirin N.N.

Yaroslavl State Medical University

RSCI AuthorID: 523232
Scopus AuthorID: 6603682550
ORCID: 0000-0001-9078-589X

Kasatkin D.S.

Yaroslavl State Medical University

Stepanov I.O.

Clinical hospital No. 2

Shipova E.G.

Yaroslavl State Medical University

Baranova N.S.

Yaroslavl State Medical University

Vinogradova T.V.

Yaroslavl State Medical University

Molchanova S.S.

Yaroslavl State Medical University

Kiselev D.V.

Yaroslavl State Medical University

Shadrichev V.A.

Yaroslavl State Medical University

Spirina N.N.

Yaroslavl State Medical University

SPIN RSCI: 1222-6768
Scopus AuthorID: 55673137900
ORCID: 0000-0002-5883-1216

Kachura D.A.

Yaroslavl regional clinical hospital

Received:

14.05.2020

Accepted:

16.05.2020

Close metadata

References:

Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. https://doi.org/10.1002/ana.22366
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. https://doi.org/10.1016/S1474-4422(17)30470-2
Bezzini D, Battaglia MA. Multiple Sclerosis Epidemiology in Europe. Adv Exp Med Biol. 2017;958:141-159. https://doi.org/10.1007/978-3-319-47861-6_9
Koch-Henriksen N, Laursen B, Stenager E, Magyari M. Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study. J Neurol Neurosurg Psychiatry. 2017;88(8):626-631. https://doi.org/10.1136/jnnp-2017-315907
Correale J, Gaitán MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 2017;140(3):527-546. https://doi.org/10.1093/brain/aww258
Rosati G, Aiello I, Mannu L, Pirastru MI, Agnetti V, Sau G, Garau M, Gioia R, Sanna G. Incidence of multiple sclerosis in the town of Sassari, Sardinia, 1965 to 1985: evidence for increasing occurrence of the dis-ease. Neurology. 1988;38:384-388. https://doi.org/10.1212/wnl.38.3.384
Montomoli C, Allemani C, Solinas G, Motta G, Bernardinelli L, Clemente S, Murgia BS, Ticca AF, Musu L, Piras ML, Ferrai R, Caria A, Sanna S, Porcu O. An ecologic study of geographicalvariation in multiple sclerosis risk in central Sardinia, Italy. Neuroepidemiology. 2002;21:187-193. https://doi.org/10.1159/000059522
Papathanasopoulos P, Gourzoulidou E, Messinis L, Georgiou V, Leotsinidis M. Prevalence and inci-dence of multiple sclerosis in western Greece: a 23-year survey. Neuroepidemiology. 2008;30(3):167-173. https://doi.org/10.1159/000122334
Potemkowski A. Multiple sclerosis in Poland and worldwide—epidemiological considerations. Aktualn Neurol. 2009;9:91-97.
Brola W, Sobolewski P, Flaga S, Fudala M, Jantarski K. Increasing prevalence and incidence of multiple sclerosis in Poland. Neurol Neurochir Pol. 2017;51(1):82-85. https://doi.org/10.1016/j.pjnns.2016.11.005
Ribbons K, Lea R, Tiedeman C, Mackenzie L, Lechner-Scott J. Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study. Mult Scler. 2017;23(8):1063-1071. https://doi.org/10.1177/1352458516671819
Aliferova VM, Titova MA. Clinical characteristics of multiple sclerosis sclerosis in the Tomsk region. Journal of neurology and psychiatry named after S. S. Korsakov. 2013;10(2):15-17. (In Russ.). https://doi.org/10.17116/jnevro201711710259-90
Malkova NA, Shperling LP. Epidemiology of multiple sclerosisfor in Novosibirsk. Bulletin of SB RAS. 2005;4(118):113-118. (In Russ.)
Boyko AN, Smirnova NF, Zolotova SN, Gusev EI. Epidemiologia and etiology of multiple sclerosis. Consilium Medicum. 2008;07:5-8. (In Russ.).
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13(3):227-231.
Di Pauli F, Reindl M, Ehling R, Schautzer F, Gneiss C, Lutterotti A, O’Reilly E, Munger K, Deisenhammer F, Ascherio A, Berger T. Smoking is a risk factorfor early conversion to clinically definite multiple sclerosis. Mult Scler. 2008;148:1026-1030.
Koch M, van Harten A, Uyttenboogaart M, De Keyser J. Cigarette smoking and progression in multiple sclerosis. Neurology. 2007;69(15):1515-1520.